US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 6, 2019 (7 years ago)

MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

What was recalled

MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India NDC 68382-916-01

Recalling firm
Zydus Pharmaceuticals USA Inc
NDC code
68382-916-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1448-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methylprednisolone recalls

See all